title: A trial of thyroxine in acute renal failure.
abstract: A trial of thyroxine in acute renal failure.
  
  
  BACKGROUND
  Acute renal failure (ARF) remains a serious medical problem with a high mortality rate. Efforts to shorten the course of ARF might reduce this mortality. Since thyroxine has been shown in experimental models to shorten the course of ARF, we designed a trial to determine if a defined course of thyroxine would alter the course or change the mortality of clinical ARF.
  
  
  METHODS
  A prospective, randomized, placebo-controlled, double-blind trial of thyroxine was carried out in patients with ARF. End points were the percentage requiring dialysis, the percentage recovering renal function, time to recovery, and mortality.
  
  
  RESULTS
  Fifty-nine patients were randomized to receive either thyroxine or placebo. The groups were well matched in terms of basal and entry creatinines, age, sex, APACHE II scores at entry, and percentage oliguric. Baseline thyroid functions, including T3, T4, rT3, and thyroid stimulating hormone (TSH) levels, were equal between the two groups and typical of patients with euthyroid sick syndrome. Thyroxine resulted in a progressive and sustained suppression of TSH levels in the treated group, but had no effect on any measure of ARF severity. Mortality was higher in the thyroxine group than the control group (43 vs. 13%) and correlated with suppression of TSH.
  
  
  CONCLUSIONS
  In contrast to the beneficial effects seen in experimental ARF, thyroxine has no effect on the course of clinical ARF and could have a negative effect on outcome through prolonged suppression of TSH. Critically ill euthyroid sick patients should not be replaced with thyroid hormone.
authors.affiliation: Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh, Pennsylvania, USA.
authors.forename: C G
authors.initials: CG
authors.lastname: Acker
authors.forename: A R
authors.initials: AR
authors.lastname: Singh
authors.forename: R P
authors.initials: RP
authors.lastname: Flick
authors.forename: J
authors.initials: J
authors.lastname: Bernardini
authors.forename: A
authors.initials: A
authors.lastname: Greenberg
authors.forename: J P
authors.initials: JP
authors.lastname: Johnson
mesh_terms: D018806:APACHE; D058186:Acute Kidney Injury / Q000188:drug therapy* / Q000473:pathology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013974:Thyroxine / Q000627:therapeutic use*
chemical_list: D013974:Thyroxine